Jeanna Knoble

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.2K citations

Medicine, Oncology, Pharmacology +14

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Clinical Sciences, Oncology +8

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 687 citations · Full text

Medicine, Oncology, Pharmacology +14

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

Julie Fu, Sonya Reid, Benjamin French et al. · JAMA Network Open · 2022 · 72 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

Ziad Bakouny, Chris Labaki, Punita Grover et al. · JAMA Oncology · 2022 · 62 citations · Full text

Life Sciences, Immunology, Oncology +17